title: Should hysterectomy complement prophylactic salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers?
authors.affiliation: Department of Gynecologic Oncology, Princess Margaret Cancer Center, Ontario Cancer Institute, Toronto, ON, Canada.
authors.forename: Iryna
authors.initials: I
authors.lastname: Vyarvelska
authors.affiliation: Department of Gynecologic Oncology, Princess Margaret Cancer Center, Ontario Cancer Institute, Toronto, ON, Canada.
authors.forename: Barry
authors.initials: B
authors.lastname: Rosen
authors.affiliation: Women's College Research Institute, Toronto, ON, Canada and the Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada. Electronic address: steven.narod@wchospital.ca.
authors.forename: Steven A
authors.initials: SA
authors.lastname: Narod
mesh_terms: D005187:Fallopian Tubes / Q000601:surgery; D005260:Female; D019398:Genes, BRCA1; D024522:Genes, BRCA2; D006579:Heterozygote; D006801:Humans; D007044:Hysterectomy; D009154:Mutation; D010052:Ovariectomy; D017410:Practice Guidelines as Topic; D058994:Salpingectomy; D014594:Uterine Neoplasms / Q000235:genetics* / Q000517:prevention & control*